Recent 8-K filings for PURR

• May 07, 2026 23:59 UTC earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Hyperliquid Strategies Q3 net profit of $152.5M on HYPE gains; treasury grows to 20M tokens

  Q3 net profit of $152.5M, driven by $198.4M unrealized gains on HYPE tokens, partially offset by $42.7M deferred tax expense.

• Feb 18, 2026 23:59 UTC m_and_a materiality 0.50 neutral item 9.01

  Hyperliquid Strategies files audited Sonnet FY2025 financials after combo

  Sonnet's audited financials for FY ended Sep 30, 2025 filed; pro forma data included.

• Feb 11, 2026 23:59 UTC earnings materiality 0.80 negative item 2.02item 7.01item 9.01

  Hyperliquid Strategies reports $317.9M net loss for H1 FY2026; HYPE holdings 17.6M

  Six-month net loss of $317.9M, driven by $262.4M unrealized loss on HYPE tokens and $35.6M IPR&D write-off.

• Dec 08, 2025 23:59 UTC other_material materiality 0.60 positive item 7.01item 9.01

  Hyperliquid Strategies announces $30M share repurchase program

  Board authorized repurchase of up to $30M of common stock over 12 months.

• Dec 03, 2025 23:59 UTC m_and_a materiality 0.90 neutral item 2.01item 1.01item 3.02item 3.03item 5.03item 5.01item 5.02item 5.05item 7.01item 8.01item 9.01

  Hyperliquid Strategies completes business combination; trades as PURR on Nasdaq Dec 3

  Closed acquisition of Sonnet BioTherapeutics and Rorschach I LLC; combined entity has ~127M shares outstanding.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.90 · Median 0.75 · Most common event earnings

2 positive 1 negative 2 neutral

source · PURR on sec.gov